Literature DB >> 4334408

International collaborative studies on the pertussis vaccine potency assay. Part played by the challenge in the mouse-protection test.

R Murata, F T Perkins, M Pittman, I Scheibel, K Sladký.   

Abstract

Because of wide variations in the methods used to assay the potency of pertussis vaccine, the effect of the type of challenge used in the mouse-protection test was studied. Eight laboratories took part in a collaborative investigation and the potencies of 4 pairs of vaccines were estimated. Two methods were used, a "local method" using local strains and procedures for challenge, and a "study method" using a distributed strain and a specified procedure. For both methods the challenge level (mouse LD(50)) and the number of colony-forming units per challenge dose varied greatly between laboratories.The results of the collaborative assay show that the use of a common challenge, Bordetella pertussis strain 18-323, and a uniform method for preparing the challenge did not reduce the heterogeneity of the results. Other factors influencing the results of potency assays, such as the use of different strains of mice and the effect of levels of challenge, have still to be investigated.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4334408      PMCID: PMC2427852     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH.

Authors:  N W PRESTON
Journal:  Br Med J       Date:  1963-09-21

2.  Pertussis Vaccine Prepared with Phase-I Cultures Grown in Fluid Medium.

Authors:  S M Cohen; M W Wheeler
Journal:  Am J Public Health Nations Health       Date:  1946-04

3.  Mouse-protective properties of Bordetella pertussis serotypes in passive tests.

Authors:  G Eldering; J Holwerda; J Baker
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

4.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  4 in total
  1 in total

1.  The Kendrick-Eldering-(Frost) pertussis vaccine field trial.

Authors:  Harry M Marks
Journal:  J R Soc Med       Date:  2007-05       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.